Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;65(6):1131-1139.
doi: 10.1016/j.jhep.2016.07.021. Epub 2016 Jul 27.

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging

Affiliations

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging

Naaventhan Palaniyappan et al. J Hepatol. 2016 Dec.

Abstract

Background & aims: Hepatic venous pressure gradient (HVPG) measurement is currently the only validated technique to accurately evaluate changes in portal pressure. In this study, we evaluate the use of non-contrast quantitative magnetic resonance imaging (MRI) as a surrogate measure of portal pressure.

Methods: Thirty patients undergoing HVPG measurement were prospectively recruited. MR parameters of longitudinal relaxation time (T1), perfusion of the liver and spleen (by arterial spin labelling), and blood flow in the portal, splanchnic and collateral circulation (by phase contrast MRI) were assessed. We estimated the liver stiffness measurement (LSM) and enhanced liver fibrosis (ELF) score. The correlation of all non-invasive parameters with HVPG was evaluated.

Results: The mean (range) HVPG of the patients was 9.8 (1-22) mmHg, and 14 patients (48%) had clinically significant portal hypertension (CSPH, HVPG ⩾10mmHg). Liver T1 relaxation time, splenic artery and superior mesenteric artery velocity correlated significantly with HVPG. Using multiple linear regression, liver T1 and splenic artery velocity remained as the two parameters in the multivariate model significantly associated with HVPG (R=0.90, p<0.001). This correlation was maintained in patients with CSPH (R=0.85, p<0.001). A validation cohort (n=10) showed this linear model provided a good prediction of HVPG. LSM and ELF score correlated significantly with HVPG in the whole population but the correlation was absent in CSPH.

Conclusions: MR parameters related to both hepatic architecture and splanchnic haemodynamics correlate significantly with HVPG. This proposed model, confirmed in a validation cohort, could replace the invasive HVPG measurement.

Lay summary: In patients with cirrhosis, the development and progression of portal hypertension is related to worse outcomes. However, the standard technique of assessing portal pressure is invasive and not widely used in clinical practice. Here, we have studied the use of non-invasive MRI in evaluating portal pressure. The MRI measures of liver architecture and blood flow in the splenic artery correlated well with portal pressure. Therefore, this non-invasive method can potentially be used to assess portal pressure in clinical trials and monitoring treatment in practice.

Keywords: Hepatic venous pressure gradient; Longitudinal T(1) relaxation time; Magnetic resonance imaging; Portal hypertension.

PubMed Disclaimer

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Correlation between HVPG and serum markers of liver fibrosis. (A) Enhanced Liver Fibrosis (ELF) score, (B) hyaluronic acid (HA), (C) aminoterminal peptide of procollagen III (P3NP) and (D) tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) concentrations.
Fig. 2
Fig. 2
Correlation of HVPG with imaging markers of liver fibrosis. (A) liver stiffness measurement (LSM), (B) liver SE-EPI T1 relaxation time (ms) and (C) the full-width-half-maximum (FWHM) of liver SE-EPI T1 Gaussian distribution (ms).
Fig. 3
Fig. 3
Example of T1 relaxation maps. Top row shows example image quality of the coronal-oblique imaging slices for base equilibrium M0 data acquired from a patient with HVPG of 3 mmHg. Subsequent rows show example coronal-oblique bFFE T1∗ maps showing the liver and spleen, together with HVPG (mmHg) and mode of the liver T1∗ value (ms) across a range of HVPG from 3–22 mmHg, with columns showing each of the five slices collected for the T1∗ map.
Fig. 4
Fig. 4
Correlation of HVPG with splanchnic and collateral flow. (A) superior mesenteric artery (SMA) velocity, (B) splenic artery (SA) velocity and (C) azygous vein (AZV) flow.
Fig. 5
Fig. 5
Predictive MRI model for HVPG. Bland-Altman plot showing the difference between measured and predicted HVPG against the measured HVPG using (A) liver SE-EPI T1 relaxation time alone, and (B) predictive MR model of liver SE-EPI T1 relaxation time and splenic artery velocity. Data shown for original (blue diamonds) and validation cohort (red squares), with mean difference (solid line) and ±1.96 standard deviations (broken line) shown.

Comment in

References

    1. Reynaert H., Thompson M.G., Thomas T., Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 2002;50:571–581. - PMC - PubMed
    1. Groszmann R.J., Wongcharatrawee S. The hepatic venous pressure gradient: Anything worth doing should be done right. Hepatology. 2004;39:280–282. - PubMed
    1. Groszmann R.J., Garcia-Tsao G., Bosch J., Grace N.D., Burroughs A.K., Planas R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–2261. - PubMed
    1. Ripoll C., Groszmann R., Garcia-Tsao G., Grace N., Burroughs A., Planas R. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–488. - PubMed
    1. Ripoll C., Groszmann R.J., Garcia-Tsao G., Bosch J., Grace N., Burroughs A. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50:923–928. - PMC - PubMed